balance equationreview2023-12-30
Difference 2135000 exceeds tolerance 1612985.000. Presentation or filing-vintage differences need review.
Revenue
$2.43B
Fiscal year ended 2026-01-03Operating income
$256.46M
Fiscal year ended 2026-01-03Free cash flow
Unavailable
Fiscal year ended 2026-01-03Aveanna Healthcare Holdings, Inc. (AVAH) reported revenue of $2.43B and net income of $225.03M for the fiscal year ended 2026-01-03. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Aveanna Healthcare Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Home Health Care Services.
Income
| Metric | 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | 2021-01-02 | 2019-12-28 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.43B | $2.02B | $1.90B | $1.79B | $1.68B | $1.50B | $1.38B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | $810.48M | $635.54M | $595.43M | $553.23M | $542.40M | $454.52M | $419.25M |
| Operating income | $256.46M | $139.79M | $8.07M | -$642.28M | -$36.11M | -$3.49M | $38.95M |
| Net income | $225.03M | -$10.93M | -$134.52M | -$662.03M | -$117.04M | -$57.05M | -$76.52M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 214.98M | shares 192.89M | shares 189.96M | shares 185.55M | Unavailable | Unavailable | Unavailable |
| Pretax income | $106.95M | $5.07M | -$139.00M | -$663.81M | -$113.58M | -$51.73M | -$75.03M |
| Income tax expense | -$118.09M | $16.00M | -$4.47M | -$1.78M | $3.47M | $5.32M | $1.49M |
| Diluted EPS | $1.05 | $-0.06 | $-0.71 | $-3.57 | $-0.69 | Unavailable | Unavailable |
| Selling, general & administrative | $374.50M | $352.81M | $360.98M | $357.23M | $297.38M | $240.95M | $227.76M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | 2021-01-02 | 2019-12-28 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $193.26M | $84.29M | $43.94M | $19.22M | $30.49M | $137.34M | Unavailable |
| Total assets | $2.01B | $1.66B | $1.61B | $1.71B | $2.33B | $1.84B | Unavailable |
| Current assets | $560.23M | $392.67M | $314.89M | $269.75M | $279.22M | $340.64M | Unavailable |
| Total liabilities | $1.82B | $1.79B | $1.74B | $1.72B | $1.70B | $1.58B | Unavailable |
| Current liabilities | $424.46M | $402.17M | $354.76M | $326.50M | $344.83M | $260.41M | Unavailable |
| Total equity incl. NCI | $194.46M | -$123.55M | -$129.57M | -$6.31M | $635.82M | $265.03M | $270.19M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $313.36M | $265.19M | $236.56M | $221.24M | $218.92M | $172.89M | Unavailable |
| Goodwill | $1.12B | $1.05B | $1.05B | $1.16B | $1.84B | $1.32B | $1.23B |
| Long-term debt | $1.29B | $1.27B | $1.28B | $1.28B | $1.23B | $1.16B | Unavailable |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Cash flow
| Metric | 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | 2021-01-02 | 2019-12-28 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $125.86M | $32.64M | $22.67M | -$48.40M | -$11.35M | $116.62M | -$8.71M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | $15.95M | $15.24M | $16.64M |
| Investing cash flow | -$22.30M | -$6.32M | -$8.79M | -$25.29M | -$681.83M | -$193.54M | -$17.82M |
| Financing cash flow | $5.41M | $14.03M | $10.85M | $62.42M | $586.33M | $210.94M | $21.86M |
| Net change in cash | $108.97M | $40.35M | $24.72M | -$11.27M | -$106.86M | $134.02M | -$4.67M |
| Stock-based compensation | $25.06M | $17.46M | $13.16M | $15.89M | $14.42M | $3.28M | $1.95M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $10.54M | $10.78M | $13.78M | $21.31M | $20.55M | $17.03M | $14.32M |
Derived
| Metric | 2026-01-03 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2022-01-01 | 2021-01-02 | 2019-12-28 |
|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $101.38M | -$25.35M |
| Gross margin | 33.3% | 31.4% | 31.4% | 30.9% | 32.3% | 30.4% | 30.3% |
| Operating margin | 10.5% | 6.9% | 0.4% | -35.9% | -2.2% | -0.2% | 2.8% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 6.8% | -1.8% |
| SBC / revenue | 1.0% | 0.9% | 0.7% | 0.9% | 0.9% | 0.2% | 0.1% |
| Current ratio | 1.32x | 0.98x | 0.89x | 0.83x | 0.81x | 1.31x | Unavailable |
| Revenue YoY growth | 20.2% | 6.8% | 6.0% | 6.5% | 12.3% | 8.0% | Unavailable |
| Net margin | 9.2% | -0.5% | -7.1% | -37.0% | -7.0% | -3.8% | -5.5% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 1.0% | 1.2% |
| Long-term debt / equity | 6.62x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | -110.4% | 315.5% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AVAH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-14View SEC filing
10-K · Filed 2026-03-19View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Reconciliation checks needing review
3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
balance equationreview2022-12-31
Difference 2135000 exceeds tolerance 1711760.000. Presentation or filing-vintage differences need review.
balance equationreview2021-01-02
Difference 2135000 exceeds tolerance 1844016.000. Presentation or filing-vintage differences need review.